Suri Anish 4
4 · Cue Biopharma, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-06-05+150,000→ 150,000 totalExercise: $1.65Exp: 2034-06-04→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024.